Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVIDMES: WJ-MSC for COVID-19 ARDS
NCT04390139Phase 2Completed
- Sponsor
- Banc de Sang i Teixits
- Start
- May 2020
- Primary completion
- Dec 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Banc de Sang i Teixits. Started May 2020; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04390139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04390139.